Timothy S. Huval Sells 3,703 Shares of Humana Inc. (NYSE:HUM) Stock

Humana Inc. (NYSE:HUM) insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Humana Stock Performance

Humana stock opened at $262.47 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $471.37. The stock has a fifty day moving average of $272.60 and a two-hundred day moving average of $313.96. The company has a market capitalization of $31.60 billion, a price-to-earnings ratio of 23.25, a PEG ratio of 2.12 and a beta of 0.55.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, analysts anticipate that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.35%. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on HUM shares. Wells Fargo & Company lowered their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target on the stock in a research note on Tuesday, October 8th. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Finally, Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and cut their target price for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $300.50.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. PDT Partners LLC grew its position in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares during the period. Ontario Teachers Pension Plan Board boosted its stake in Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares during the last quarter. Swedbank AB grew its holdings in Humana by 3.0% in the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after buying an additional 3,085 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in shares of Humana during the 3rd quarter valued at about $948,000. Finally, Heritage Oak Wealth Advisors LLC acquired a new position in shares of Humana during the 2nd quarter valued at about $3,456,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.